Mri Interventions (MRIC) 0.2149 $MRIC
MRI Interventions' ClearPoint(R) Neuro Navigation System to be Featured at ASSFN Biennial Meeting
GlobeNewswire - Wed Jun 15, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced that its ClearPoint Neuro Navigation System will be featured in a Symposium, titled "Real-Time IMRI Guidance and Laser Ablation Move into the Mainstream," on Sunday, June 19, 2016 at the Biennial Meeting of the American Society for Stereotactic and Functional Neurosurgery (ASSFN) taking place on June 18 through 21, 2016 in Chicago, Illinois.
MRI Interventions' Clearpoint(R) Neuro Navigation System Utilized For the First Time at Childrens Healthcare of Atlanta
ACCESSWIRE - Tue Jun 07, 8:02AM CDT
IRVINE, CA / ACCESSWIRE / June 7, 2016 / MRI Interventions, Inc. (OTCQB: MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced the first ClearPoint enabled pediatric laser ablation at Children's Healthcare of Atlanta at Scottish Rite.
MRI Interventions to Present at LD Micro Invitational Conference
ACCESSWIRE - Thu Jun 02, 3:30PM CDT
IRVINE, CA / ACCESSWIRE / June 2, 2016 / MRI Interventions, Inc. (OTCQB: MRIC) today announced that Frank Grillo, President and CEO, will present at the LD Micro Invitational conference in Los Angeles, CA on Thursday, June 9, 2016 at 8:30 a.m. Pacific Time.
MRI Interventions' Clearpoint(R) Neuro Navigation System Utilized For the First Time at Inova Fairfax Hospital
ACCESSWIRE - Tue May 31, 3:30PM CDT
IRVINE, CA / ACCESSWIRE / May 31, 2016 / MRI Interventions, Inc. (OTCQB: MRIC), a commercial stage medical device company focused on creating innovative neuro navigation platforms for performing minimally invasive surgical procedures in the brain, today announced the completion of the first deep brain stimulation (DBS) procedure at the Inova Fairfax Hospital in Falls Church, VA, using the Company's ClearPoint Neuro Navigation System.
MRI Interventions, Inc. Announces 2016 First Quarter Results
ACCESSWIRE - Thu Apr 28, 3:13PM CDT
Company Sets Quarterly Records in Number of ClearPoint® Procedures and Disposable Product Revenues
The ClearPoint(R) Neuro Navigation System Featured at AANS Practical Clinics for Third Consecutive Year
GlobeNewswire - Tue Apr 26, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be utilized in two Practical Clinics at the Annual Meeting of the American Association of Neurological Surgeons (AANS) taking place on April 30 through May 4, 2016, in Chicago, Illinois. Both the lecture session and hands-on workshop will focus on advanced stereotactic techniques for implantation of electrodes and placement of laser ablation catheters for neurological procedures. Following the Practical Clinics, AANS attendees are invited to visit the MRI Interventions booth (#4804) to learn about ClearPoint Neuro Navigation and real-time MRI guided technologies enabling surgeons to perform a wide range of minimally-invasive neurosurgical procedures.
MRI Interventions, Inc. Announces Fiscal 2016 First Quarter Financial Results Conference Call and Webcast
GlobeNewswire - Mon Apr 25, 4:30PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management's broadcast review of the Company's 2016 first quarter results.
Zero DBS Electrode Infections Reported When Utilizing the ClearPoint(R) NeuroNavigation System in an MRI Suite
GlobeNewswire - Wed Apr 20, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced the results of a 10 year study in which Deep Brain Stimulation (DBS) leads were implanted in a diagnostic MRI suite. The study was published in the March, 2016 issue of the Journal of Neurosurgery and outlines a 10 year history of 164 interventional MRI Deep Brain Stimulation procedures, in which 272 leads were implanted. All electrode placement procedures were performed at the University of California San Francisco (UCSF) Medical Center in a diagnostic 1.5T MRI scanner, and patients returned 1-3 weeks later to undergo placement of the implantable pulse generator (IPG) in a conventional operating room. After mid 2010 the electrode implant procedure was performed entirely in the diagnostic MRI suite using the ClearPoint NeuroNavigation System and accessories. There were zero infections related to electrode placement in all 115 electrode implant procedures using the ClearPoint System.
MRI Interventions, Inc. Announces 2015 Fourth Quarter and Full Year Results
GlobeNewswire - Wed Mar 23, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced financial results for the fourth quarter and full year ended December 31, 2015.
MRI Interventions, Inc. Announces Fiscal 2015 Fourth Quarter and Full Year Financial Results Conference Call and Webcast
GlobeNewswire - Tue Mar 22, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management's broadcast review of the Company's 2015 fourth quarter and full year results.
MRI Interventions, Inc. Announces Agreement to Restructure Brainlab AG Senior Secured Note
GlobeNewswire - Tue Mar 22, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced it has reached a definitive agreement with Brainlab AG to restate and restructure the Amended and Restated Secured Note issued by MRIC to Brainlab on March 6, 2013, effective April 4, 2016.
MRI Interventions' ClearPoint(R) Neuro Navigation System Reaches Milestone With Its 1,000th Procedure
GlobeNewswire - Tue Feb 09, 7:30AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System was utilized for its 1,000 neurosurgical procedure.
MRI Interventions, Inc. Announces 2015 Fourth Quarter and Full Year Revenues
GlobeNewswire - Thu Jan 07, 3:30PM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced its revenues for the fourth quarter and full year ended December 31, 2015.
MRI Interventions expects USD5.3m from private placement of units
M2 - Thu Dec 17, 3:39AM CST
Minimally invasive procedure company MRI Interventions (OTCBB:MRIC) revealed on Wednesday that it has entered into a definitive securities purchase agreement with a group of investors for expected gross proceeds of about USD5.3m, before deducting placement agents' fees and estimated offering expenses.
MRI Interventions Announces $5.3 Million Private Placement
GlobeNewswire - Tue Dec 15, 3:02PM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced it has entered into a definitive securities purchase agreement with a group of investors which will result in gross proceeds to MRI Interventions of approximately $5.3 million, before deducting placement agents' fees and estimated offering expenses. The placement consists of 16,309,270 units, composed of an aggregate of approximately 16,309,270 shares of its common stock, Series A Warrants to purchase approximately 6,523,726 shares of its common stock and Series B Warrants to purchase approximately 4,892,819 shares of its common stock.
MRI Interventions' ClearPoint(R) Neuro Navigation System to be Featured at ASSFN Biennial Meeting
GlobeNewswire - Wed Jun 15, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced that its ClearPoint Neuro Navigation System will be featured in a Symposium, titled "Real-Time IMRI Guidance and Laser Ablation Move into the Mainstream," on Sunday, June 19, 2016 at the Biennial Meeting of the American Society for Stereotactic and Functional Neurosurgery (ASSFN) taking place on June 18 through 21, 2016 in Chicago, Illinois.
MRI Interventions' Clearpoint(R) Neuro Navigation System Utilized For the First Time at Childrens Healthcare of Atlanta
ACCESSWIRE - Tue Jun 07, 8:02AM CDT
IRVINE, CA / ACCESSWIRE / June 7, 2016 / MRI Interventions, Inc. (OTCQB: MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced the first ClearPoint enabled pediatric laser ablation at Children's Healthcare of Atlanta at Scottish Rite.
MRI Interventions to Present at LD Micro Invitational Conference
ACCESSWIRE - Thu Jun 02, 3:30PM CDT
IRVINE, CA / ACCESSWIRE / June 2, 2016 / MRI Interventions, Inc. (OTCQB: MRIC) today announced that Frank Grillo, President and CEO, will present at the LD Micro Invitational conference in Los Angeles, CA on Thursday, June 9, 2016 at 8:30 a.m. Pacific Time.
MRI Interventions' Clearpoint(R) Neuro Navigation System Utilized For the First Time at Inova Fairfax Hospital
ACCESSWIRE - Tue May 31, 3:30PM CDT
IRVINE, CA / ACCESSWIRE / May 31, 2016 / MRI Interventions, Inc. (OTCQB: MRIC), a commercial stage medical device company focused on creating innovative neuro navigation platforms for performing minimally invasive surgical procedures in the brain, today announced the completion of the first deep brain stimulation (DBS) procedure at the Inova Fairfax Hospital in Falls Church, VA, using the Company's ClearPoint Neuro Navigation System.
MRI Interventions, Inc. Announces 2016 First Quarter Results
ACCESSWIRE - Thu Apr 28, 3:13PM CDT
Company Sets Quarterly Records in Number of ClearPoint® Procedures and Disposable Product Revenues
The ClearPoint(R) Neuro Navigation System Featured at AANS Practical Clinics for Third Consecutive Year
GlobeNewswire - Tue Apr 26, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be utilized in two Practical Clinics at the Annual Meeting of the American Association of Neurological Surgeons (AANS) taking place on April 30 through May 4, 2016, in Chicago, Illinois. Both the lecture session and hands-on workshop will focus on advanced stereotactic techniques for implantation of electrodes and placement of laser ablation catheters for neurological procedures. Following the Practical Clinics, AANS attendees are invited to visit the MRI Interventions booth (#4804) to learn about ClearPoint Neuro Navigation and real-time MRI guided technologies enabling surgeons to perform a wide range of minimally-invasive neurosurgical procedures.
MRI Interventions, Inc. Announces Fiscal 2016 First Quarter Financial Results Conference Call and Webcast
GlobeNewswire - Mon Apr 25, 4:30PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management's broadcast review of the Company's 2016 first quarter results.
Zero DBS Electrode Infections Reported When Utilizing the ClearPoint(R) NeuroNavigation System in an MRI Suite
GlobeNewswire - Wed Apr 20, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced the results of a 10 year study in which Deep Brain Stimulation (DBS) leads were implanted in a diagnostic MRI suite. The study was published in the March, 2016 issue of the Journal of Neurosurgery and outlines a 10 year history of 164 interventional MRI Deep Brain Stimulation procedures, in which 272 leads were implanted. All electrode placement procedures were performed at the University of California San Francisco (UCSF) Medical Center in a diagnostic 1.5T MRI scanner, and patients returned 1-3 weeks later to undergo placement of the implantable pulse generator (IPG) in a conventional operating room. After mid 2010 the electrode implant procedure was performed entirely in the diagnostic MRI suite using the ClearPoint NeuroNavigation System and accessories. There were zero infections related to electrode placement in all 115 electrode implant procedures using the ClearPoint System.
MRI Interventions, Inc. Announces 2015 Fourth Quarter and Full Year Results
GlobeNewswire - Wed Mar 23, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced financial results for the fourth quarter and full year ended December 31, 2015.
MRI Interventions, Inc. Announces Fiscal 2015 Fourth Quarter and Full Year Financial Results Conference Call and Webcast
GlobeNewswire - Tue Mar 22, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management's broadcast review of the Company's 2015 fourth quarter and full year results.
MRI Interventions, Inc. Announces Agreement to Restructure Brainlab AG Senior Secured Note
GlobeNewswire - Tue Mar 22, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced it has reached a definitive agreement with Brainlab AG to restate and restructure the Amended and Restated Secured Note issued by MRIC to Brainlab on March 6, 2013, effective April 4, 2016.
MRI Interventions' ClearPoint(R) Neuro Navigation System Reaches Milestone With Its 1,000th Procedure
GlobeNewswire - Tue Feb 09, 7:30AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System was utilized for its 1,000 neurosurgical procedure.
MRI Interventions, Inc. Announces 2015 Fourth Quarter and Full Year Revenues
GlobeNewswire - Thu Jan 07, 3:30PM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced its revenues for the fourth quarter and full year ended December 31, 2015.
MRI Interventions expects USD5.3m from private placement of units
M2 - Thu Dec 17, 3:39AM CST
Minimally invasive procedure company MRI Interventions (OTCBB:MRIC) revealed on Wednesday that it has entered into a definitive securities purchase agreement with a group of investors for expected gross proceeds of about USD5.3m, before deducting placement agents' fees and estimated offering expenses.
MRI Interventions Announces $5.3 Million Private Placement
GlobeNewswire - Tue Dec 15, 3:02PM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced it has entered into a definitive securities purchase agreement with a group of investors which will result in gross proceeds to MRI Interventions of approximately $5.3 million, before deducting placement agents' fees and estimated offering expenses. The placement consists of 16,309,270 units, composed of an aggregate of approximately 16,309,270 shares of its common stock, Series A Warrants to purchase approximately 6,523,726 shares of its common stock and Series B Warrants to purchase approximately 4,892,819 shares of its common stock.
